Parexel alternatives
Companies similar to Parexel on cro.directory, ranked by shared capabilities and locations focusing on Vaccine, Cell Therapy, Gene Therapy, and Translational Research. Below are the top 10 cros with overlapping structured profile data.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares Translational Research, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares Regulatory Affairs, Pharmacovigilance & Drug Safety, Medical Writing, and Biostatistics & Statistical Programming.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
Shares EU EMA Regulatory Strategy, US FDA Regulatory Strategy, Regulatory Affairs, and Pharmacovigilance & Drug Safety.
Shares Translational Research, Regulatory Affairs, Pharmacovigilance & Drug Safety, and Medical Writing.
Shares Translational Research, Regulatory Affairs, Pharmacovigilance & Drug Safety, and Medical Writing.
How we pick similar companies: alternatives similarity uses shared services, modalities, locations, and site-specific capability fields — not sponsorship. Missing fields stay blank. Data comes from structured directory profiles.
Interactive comparison
Lock shared capabilities to filter peers. Locked views are not indexed — the canonical page stays unlocked.
Capability locks
- Accelsiors
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- IQVIA
Shares Translational Research, China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, and EU EMA Regulatory Strategy.
- MMS Holdings
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- Fortrea
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- Clinical Research Network India Pvt. Ltd.
Shares Regulatory Affairs, Pharmacovigilance & Drug Safety, Medical Writing, and Biostatistics & Statistical Programming.
- PPD
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- Citeline
Shares China NMPA Regulatory Strategy, Japan PMDA Regulatory Strategy, EU EMA Regulatory Strategy, and US FDA Regulatory Strategy.
- Caidya
Shares EU EMA Regulatory Strategy, US FDA Regulatory Strategy, Regulatory Affairs, and Pharmacovigilance & Drug Safety.
- Indero
Shares Translational Research, Regulatory Affairs, Pharmacovigilance & Drug Safety, and Medical Writing.
- Cytel
Shares Translational Research, Regulatory Affairs, Pharmacovigilance & Drug Safety, and Medical Writing.
Markdown mirror: /alternatives/parexel.md